Valuation: DHG Pharmaceutical

Market Cap 11,362B 440M 394M 363M 329M 614M 41.8B 626M 4.33B 1.74B 21.99B 1.65B 1.62B 69.35B P/E 2026 *
12.2x
P/E 2027 * 11.6x
Enterprise Value 9,499B 368M 330M 303M 275M 514M 34.95B 523M 3.62B 1.45B 18.38B 1.38B 1.35B 57.98B EV / Sales 2026 *
1.75x
EV / Sales 2027 * 1.67x
Free-Float
48.78%
Yield 2026 *
8.06%
Yield 2027 * 8.29%
10-20 DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 CI
08-21 DHG Pharma Announces Final Dividend for 2025, Payable on 30 Sep. 2026 CI
07-20 DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
07-14 Large Enterprise Tax Sub-Department Imposes Administrative Penalty on DHG Pharmaceutical Joint Stock Company CI
05-25 DHG Pharmaceutical Joint Stock Company Receives the Confirmation Certificate of Registration Changes CI
04-29 DHG Pharmaceutical Joint Stock Company Announces Adjustment of Position of Osamu Fujimori as Deputy General Director in Charge of Finance and Supply Chain, Effective May 1, 2026 CI
04-23 DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for 2026 CI
04-23 DHG Pharmaceutical Joint Stock Company Announces Board Changes, Effective April 21, 2026 CI
04-23 DHG Pharmaceutical Joint Stock Company Approves Dividend for the Fiscal Year Ended December 31, 2025, Payable on 28 May 2026 and in September 2026 CI
04-23 DHG Pharmaceutical Joint Stock Company Provides Dividend Guidance for the Fiscal Year 2026 CI
04-20 DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-26 DHG Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2026 CI
01-20 DHG Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
1 day-0.46%
1 week-1.14%
1 month-3.34%
3 months-6.16%
6 months-13.10%
Current year-15.05%
1 week 86,900
Extreme 86900
88,900
1 month 86,900
Extreme 86900
90,500
Current year 86,900
Extreme 86900
109,000
1 year 86,900
Extreme 86900
109,000
3 years 86,900
Extreme 86900
125,900
5 years 78,000
Extreme 78000
142,500
10 years 61,000
Extreme 60999.999999
142,500
Manager TitleAgeSince
Chief Executive Officer 59 -
Director of Finance/CFO - -
Chief Executive Officer 52 31/08/2017
Director TitleAgeSince
Director/Board Member 52 29/02/2000
Director/Board Member 70 14/08/2016
Chairman - 10/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
26/05/22 Buy

Chief Financial Officer

18,700 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-0.46%-1.14%-17.71%-13.10% 440M
+3.19%+11.31%+64.28%+155.91% 1,263B
-0.73%+3.56%+44.65%+84.17% 658B
+1.41%+3.24%+35.25%+108.88% 521B
+0.42%+3.20%+55.81%+72.50% 391B
+2.18%+2.93%+73.90%+45.59% 369B
+1.12%+4.52%+34.76%+58.24% 307B
+6.96%+8.86%+11.95%+36.20% 290B
+1.15%+6.09%+56.15%+82.25% 252B
+3.06%+9.38%+42.48%+117.32% 212B
Average +1.83%+5.21%+40.15%+74.79% 426.24B
Weighted average by Cap. +2.01%+6.60%+50.50%+100.42%

Financials

2026 *2027 *
Net sales 5,435B 211M 189M 173M 157M 294M 20B 299M 2.07B 831M 10.52B 790M 774M 33.17B 5,691B 221M 197M 182M 165M 308M 20.94B 313M 2.17B 870M 11.01B 828M 810M 34.73B
Net income 928B 35.97M 32.22M 29.64M 26.85M 50.19M 3.42B 51.13M 353M 142M 1.8B 135M 132M 5.67B 983B 38.11M 34.13M 31.39M 28.44M 53.17M 3.62B 54.16M 374M 150M 1.9B 143M 140M 6B
Net Debt -1,862B -72.17M -64.64M -59.45M -53.87M -101M -6.85B -103M -709M -285M -3.6B -271M -265M -11.37B -1,858B -71.99M -64.47M -59.3M -53.73M -100M -6.84B -102M -707M -284M -3.6B -270M -264M -11.34B
Projected Income Statement - Annual - DHG Pharmaceutical
Logo DHG Pharmaceutical
DHG Pharmaceutical Joint Stock Company is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and markets pharmaceutical products, vitamins, supplements and cosmetics. Via its subsidiaries, the Company is also involved in packaging printing, herb cultivation, medicinal supplies trading, as well as domestic travel tour and medical clinic operation.
Employees
2,812
Date Price Change Volume
30/10/26 ₫86,900.00 -0.46% 5,806
29/10/26 ₫87,300.00 -.--% 3,469
28/10/26 ₫87,300.00 -0.23% 4,221
27/10/26 ₫87,500.00 -0.34% 9,610
26/10/26 ₫87,800.00 -0.11% 4,034
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - DHG Pharmaceutical
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
86,900.00VND
Average target price
97,600.00VND
Spread / Average Target
+12.31%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - DHG Pharmaceutical